10/16/2026
DAYS LEFT TO MAKE YOIR VOICE HEARD!
š As a physician caring for women through menopause, this matters to meāand I hope it matters to you, too.
For years, Iāve cared for women who are navigating the changes of menopause and trying to find answers for symptoms that can affect their energy, sleep, sexual health, muscle strength, confidence, and overall quality of life.
One area where we still need more research, clearer guidance, and better options is testosterone therapy for women.
There is currently no FDA-approved testosterone formulation specifically designed for women in the United States. Yet testosterone is the most abundant hormone in women.
The FDAās public docket FDA-2026-N-5479 is open for comments through 11:59 PM ET on October 19, 2026.
āļø Sign the petition to show support for a clearer, evidence-based pathway for womenās testosterone care.
š Then submit your own comment to the FDA. A petition signature demonstrates support; an individual comment submitted to the FDA docket becomes part of the official record the agency is required to consider.
As a physician, I want my patients to have access to care that is evidence-based, appropriately monitored, and grounded in good science.
š Link to petition in bio.
Please share this post. The more women, patients, and healthcare professionals who participate in this conversation, the harder it is for womenās health to remain an afterthought.
MenopauseAwareness WomensHealthcare FDA